Curis Re-Initiates Dosing for CUDC-427 – Analyst Blogby Bob MitchellJune 6, 2014April 17, 2021Curis, Inc. ( CRIS ) announced that it has re initiated dosing in the single agent clinical trial on pipeline …read more